Chinese COVID-19 vaccines officially launched in the UAE
- MIT: Potent New Strategies Enhancing COVID-19 RNA Vaccines
- Long-COVID Found to Have Surprising Connection with Common Cold
- AI Accelerates Deep Brain Stimulation for Treatment-Resistant Depression
- Fentanyl and Stimulant Abuse Lead to the 4th Wave of Overdose Crisis
- New Gene Editing Tool Reduces Accidental Mutations by Over 70%
- What role do Macrophages play in Tumor Immunotherapy?
Chinese COVID-19 vaccines officially launched in the UAE
Chinese COVID-19 vaccines officially launched in the UAE. The Ministry of Health and Prevention of the United Arab Emirates announced on the 9th that it has officially registered the COVID-19 inactivated vaccine developed by China National Pharmaceutical Group.
The UAE Ministry of Health and Prevention said in a statement that according to the relevant application, the UAE has officially registered the COVID-19 inactivated vaccine developed by China National Pharmaceutical Group, which is a major vote of confidence by the UAE government in the safety and effectiveness of the vaccine.
stated that the analysis of phase III clinical trials showed that the inactivated vaccine is 86% effective against new coronavirus infection. This vaccine has a 99% seroconversion rate of neutralizing antibodies and 100% effectiveness in preventing the conversion of mild COVID-19 disease to moderate and severe cases. In addition, analysis shows that the vaccine has no serious safety risks.
In June of this year, the new coronavirus inactivated vaccine jointly developed by the Wuhan Institute of Biological Products of Sinopharm and the Wuhan Institute of Virology of the Chinese Academy of Sciences began to enter the final sprint stage. The Sinopharm International Clinical Trial (Phase III) of China’s Bio-COVID-19 Inactivated Vaccine was launched on June 23 in Abu Dhabi, UAE.
The picture shows the start of the third phase clinical trial of the “Wuhan made” COVID-19 inactivated vaccine in June 2020. The picture shows the start of the third phase clinical trial of the “Wuhan made” COVID-19 inactivated vaccine in June 2020.
On July 16, Alfang and China National Pharmaceutical Group started a phase III clinical trial of this COVID-19 vaccine. More than 31,000 volunteers from 125 countries and regions living in the UAE participated in the trial.
The UAE Ministry of Health and Prevention announced on September 14 that the UAE government approved the emergency use of the above-mentioned inactivated vaccine developed by China National Pharmaceutical Group for the first-line medical workers in the country to treat the COVID-19.
Disclaimer of medicaltrend.org
